Search research articles
Contact Us
Filters
Showing results (51-60 of 87) with videos related to
Page
of 9
Sort By:
Transplantation Research
|
January 30, 2016
The role of CYP3A5 polymorphism and dose adjustments following conversion of twice-daily to once-daily tacrolimus in renal transplant recipients
Alina S R Zaltzman, Lauren A Glick, Jeffrey S Zaltzman, et al.
Canadian Journal of Kidney Health and Disease
|
April 28, 2016
Reduction in new-onset diabetes mellitus after renal transplant with erythropoietin-stimulating agents: a retrospective cohort study
Tess Montada-Atin, Diana Choi, Minna Woo, et al.
Orphanet Journal of Rare Diseases
|
July 24, 2025
The burden of illness in Prader-Willi syndrome: a systematic literature review
Dairine Dempsey, Maria Hall, Ben Lanning, et al.
Clinical Transplantation
|
September 12, 2007
Renal transplant outcome in high-cardiovascular risk recipients
Tarun K Jeloka, Heather Ross, Robert Smith, et al.
BMC Infectious Diseases
|
April 7, 2019
Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation
G V Ramesh Prasad, Jill Beckley, Mohit Mathur, et al.
Gastroenterology
|
August 16, 2012
Once-daily budesonide MMX® extended-release tablets induce remission in patients with mild to moderate ulcerative colitis: results from the CORE I study
William J Sandborn, Simon Travis, Luigi Moro, et al.
Clinical Kidney Journal
|
February 2, 2013
A comparison of the extended-release and standard-release formulations of tacrolimus in de novo kidney transplant recipients: a 12-month outcome study
Helen Fanous, Rebecca Zheng, Carolyn Campbell, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
September 11, 2014
Metabolic syndrome definitions and components in predicting major adverse cardiovascular events after kidney transplantation
G V Ramesh Prasad, Michael Huang, Samuel A Silver, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 5, 2016
3-O-Alkyl-2,3-dehydrosilibinins: Two synthetic approaches and in vitro effects toward prostate cancer cells
Sheng Zhang, Bao Vue, Michael Huang, et al.
FEMS Yeast Research
|
April 25, 2006
Heterologous protein production in the yeast Kluyveromyces lactis
Albert J J van Ooyen, Peter Dekker, Michael Huang, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 87) with videos related to
Sort By:
Page
of 9
Transplantation Research
|
January 30, 2016
The role of CYP3A5 polymorphism and dose adjustments following conversion of twice-daily to once-daily tacrolimus in renal transplant recipients
Alina S R Zaltzman, Lauren A Glick, Jeffrey S Zaltzman, et al.
Canadian Journal of Kidney Health and Disease
|
April 28, 2016
Reduction in new-onset diabetes mellitus after renal transplant with erythropoietin-stimulating agents: a retrospective cohort study
Tess Montada-Atin, Diana Choi, Minna Woo, et al.
Orphanet Journal of Rare Diseases
|
July 24, 2025
The burden of illness in Prader-Willi syndrome: a systematic literature review
Dairine Dempsey, Maria Hall, Ben Lanning, et al.
Clinical Transplantation
|
September 12, 2007
Renal transplant outcome in high-cardiovascular risk recipients
Tarun K Jeloka, Heather Ross, Robert Smith, et al.
BMC Infectious Diseases
|
April 7, 2019
Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation
G V Ramesh Prasad, Jill Beckley, Mohit Mathur, et al.
Gastroenterology
|
August 16, 2012
Once-daily budesonide MMX® extended-release tablets induce remission in patients with mild to moderate ulcerative colitis: results from the CORE I study
William J Sandborn, Simon Travis, Luigi Moro, et al.
Clinical Kidney Journal
|
February 2, 2013
A comparison of the extended-release and standard-release formulations of tacrolimus in de novo kidney transplant recipients: a 12-month outcome study
Helen Fanous, Rebecca Zheng, Carolyn Campbell, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
September 11, 2014
Metabolic syndrome definitions and components in predicting major adverse cardiovascular events after kidney transplantation
G V Ramesh Prasad, Michael Huang, Samuel A Silver, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 5, 2016
3-O-Alkyl-2,3-dehydrosilibinins: Two synthetic approaches and in vitro effects toward prostate cancer cells
Sheng Zhang, Bao Vue, Michael Huang, et al.
FEMS Yeast Research
|
April 25, 2006
Heterologous protein production in the yeast Kluyveromyces lactis
Albert J J van Ooyen, Peter Dekker, Michael Huang, et al.
Page
of 9